Please login to the form below

Not currently logged in
Email:
Password:

leukemia

This page shows the latest leukemia news and features for those working in and with pharma, biotech and healthcare.

Imbruvica and Gazyvo approved in first non-chemo CLL use

Imbruvica and Gazyvo approved in first non-chemo CLL use

leukemia/small lymphocytic lymphoma (CLL/SLL).

Latest news

More from news
Approximately 5 fully matching, plus 48 partially matching documents found.

Latest Intelligence

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    There are also global direct-to-patient access programmes for Gleevec and Tasigna, life-saving therapies for chronic myeloid leukemia and gastrointestinal stromal tumours.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics